BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 19242781)

  • 1. The epithelial-to-mesenchymal transition and cancer stem cells: a coalition against cancer therapies.
    Hollier BG; Evans K; Mani SA
    J Mammary Gland Biol Neoplasia; 2009 Mar; 14(1):29-43. PubMed ID: 19242781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells.
    Kong D; Banerjee S; Ahmad A; Li Y; Wang Z; Sethi S; Sarkar FH
    PLoS One; 2010 Aug; 5(8):e12445. PubMed ID: 20805998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression.
    May CD; Sphyris N; Evans KW; Werden SJ; Guo W; Mani SA
    Breast Cancer Res; 2011 Feb; 13(1):202. PubMed ID: 21392411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linking EMT programmes to normal and neoplastic epithelial stem cells.
    Lambert AW; Weinberg RA
    Nat Rev Cancer; 2021 May; 21(5):325-338. PubMed ID: 33547455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AACR special conference on epithelial-mesenchymal transition and cancer progression and treatment.
    Roussos ET; Keckesova Z; Haley JD; Epstein DM; Weinberg RA; Condeelis JS
    Cancer Res; 2010 Oct; 70(19):7360-4. PubMed ID: 20823151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The epithelial-mesenchymal transition and cancer stem cells: functional and mechanistic links.
    Liu X; Fan D
    Curr Pharm Des; 2015; 21(10):1279-91. PubMed ID: 25506898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial-mesenchymal transition in cancer development and its clinical significance.
    Iwatsuki M; Mimori K; Yokobori T; Ishi H; Beppu T; Nakamori S; Baba H; Mori M
    Cancer Sci; 2010 Feb; 101(2):293-9. PubMed ID: 19961486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer.
    Vijay GV; Zhao N; Den Hollander P; Toneff MJ; Joseph R; Pietila M; Taube JH; Sarkar TR; Ramirez-Pena E; Werden SJ; Shariati M; Gao R; Sobieski M; Stephan CC; Sphyris N; Miura N; Davies P; Chang JT; Soundararajan R; Rosen JM; Mani SA
    Breast Cancer Res; 2019 Mar; 21(1):37. PubMed ID: 30845991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients.
    Aktas B; Tewes M; Fehm T; Hauch S; Kimmig R; Kasimir-Bauer S
    Breast Cancer Res; 2009; 11(4):R46. PubMed ID: 19589136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer cells in epithelial-to-mesenchymal transition and tumor-propagating-cancer stem cells: distinct, overlapping or same populations.
    Floor S; van Staveren WC; Larsimont D; Dumont JE; Maenhaut C
    Oncogene; 2011 Nov; 30(46):4609-21. PubMed ID: 21643013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells.
    Santisteban M; Reiman JM; Asiedu MK; Behrens MD; Nassar A; Kalli KR; Haluska P; Ingle JN; Hartmann LC; Manjili MH; Radisky DC; Ferrone S; Knutson KL
    Cancer Res; 2009 Apr; 69(7):2887-95. PubMed ID: 19276366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epithelial-mesenchymal transition in cancer progression].
    Gos M; Miłoszewska J; Przybyszewska M
    Postepy Biochem; 2009; 55(2):121-8. PubMed ID: 19824467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer.
    Singh A; Settleman J
    Oncogene; 2010 Aug; 29(34):4741-51. PubMed ID: 20531305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel lung metastasis signature links Wnt signaling with cancer cell self-renewal and epithelial-mesenchymal transition in basal-like breast cancer.
    DiMeo TA; Anderson K; Phadke P; Fan C; Perou CM; Naber S; Kuperwasser C
    Cancer Res; 2009 Jul; 69(13):5364-73. PubMed ID: 19549913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concise Review: Stem Cells and Epithelial-Mesenchymal Transition in Cancer: Biological Implications and Therapeutic Targets.
    Sato R; Semba T; Saya H; Arima Y
    Stem Cells; 2016 Aug; 34(8):1997-2007. PubMed ID: 27251010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revisiting epithelial-mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemness.
    Liao TT; Yang MH
    Mol Oncol; 2017 Jul; 11(7):792-804. PubMed ID: 28649800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of epithelial-mesenchymal transition in tumor progression].
    Puisieux A
    Bull Acad Natl Med; 2009 Dec; 193(9):2017-32; discussion 2032-4. PubMed ID: 20666015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urothelial cancer stem cells and epithelial plasticity: current concepts and therapeutic implications in bladder cancer.
    Garg M
    Cancer Metastasis Rev; 2015 Dec; 34(4):691-701. PubMed ID: 26328525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial-Mesenchymal Plasticity: A Central Regulator of Cancer Progression.
    Ye X; Weinberg RA
    Trends Cell Biol; 2015 Nov; 25(11):675-686. PubMed ID: 26437589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial-mesenchymal transition (EMT) in tumor-initiating cells and its clinical implications in breast cancer.
    Creighton CJ; Chang JC; Rosen JM
    J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):253-60. PubMed ID: 20354771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.